Back to STATE STREET CORP STATE STREET CORP

GALTGALT
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in GALECTIN THERAPEUTICS INC

STATE STREET CORP holds 567,779 shares of GALT (GALECTIN THERAPEUTICS INC), worth $2.6M as of 2026-Q2. The position was increased (+119.7% shares). GALT represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$2.6M

Current Shares

567,779

Total Value Change

+$1.9M

Total Shares Change

+316,765

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
567,779
+119.7%
$2.6M0.0%$4.64
42
2026-Q1
Increased
258,432
+6.7%
$721,0250.0%$2.98
18
2025-Q4
Increased
242,232
+5.2%
$1M0.0%$4.08
18
2025-Q3
Increased
230,340
+14.6%
$975,4900.0%$4.22
19
2025-Q2
Decreased
200,940
-28.3%
$423,9830.0%$2.33
0
2025-Q1
Decreased
280,314
-2.5%
$341,9830.0%$1.52
0
2024-Q4
Increased
287,514
+14.5%
$370,8930.0%$1.10
18
2024-Q3
Increased
251,014
+9.3%
$690,2890.0%$2.71
18

Other major holders of GALT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, OSAIC HOLDINGS, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used